iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
February 22, 2024 16:05 ET
|
iRhythm
SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 08, 2024 16:05 ET
|
iRhythm
SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and...
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024 08:30 ET
|
iRhythm
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
January 05, 2024 08:05 ET
|
iRhythm
CAMELOT is the largest published real-world comparative effectiveness analysis of ambulatory cardiac monitoring.
iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System
January 03, 2024 20:59 ET
|
iRhythm
SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), ein führendes Unternehmen im Bereich der digitalen Gesundheit, das sich auf die Entwicklung zuverlässiger...
iRhythm Technologies reçoit le marquage CE en vertu du règlement relatif aux dispositifs médicaux (règlement UE relatif aux DM) pour son moniteur Zio® et son système ZEUS
January 03, 2024 20:59 ET
|
iRhythm
SAN FRANCISCO, 04 janv. 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ : IRTC), une société leader dans le domaine des soins de santé numériques qui contribue à créer des solutions...
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
January 03, 2024 08:00 ET
|
iRhythm
SAN FRANCISCO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 26, 2023 16:30 ET
|
iRhythm
SAN FRANCISCO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
November 13, 2023 08:05 ET
|
iRhythm
SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of a new retrospective analysis, conducted in partnership with Duke Health, that...
iRhythm Technologies Announces Third Quarter 2023 Financial Results
November 02, 2023 16:05 ET
|
iRhythm
iRhythm Technologies, Inc. (NASDAQ: IRTC) Announces Third Quarter 2023 Financial Results